Subscribe
Webinars
White Papers
Buyer's Guide
PhotonicsNXT
Get Published!
Lasers/Sources
Detectors/Imaging
Optics
Bio & Life Sciences
Laser Processing
Test/Measurement
Science & Research
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
LFW Photonics Market Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Articles published by GlobeNewswire
< Previous
1
2
...
10
11
12
13
14
15
16
17
18
...
99
100
Next >
Ophirex Announces Business Update: Advances Toward Food and Drug Administration (FDA) Approval for Varespladib as Novel Oral Snakebite Treatment
December 11, 2025
From
Ophirex
Via
GlobeNewswire
Amaero Accelerates Growth Initiatives with Major Equipment Orders
December 11, 2025
From
Amaero Ltd
Via
GlobeNewswire
Tickers
AMROF
ASX:3DA
VEON’s Banglalink Receives Regulatory Approval to Launch Digital Payment Services to Advance Financial Inclusion in Bangladesh
December 11, 2025
From
VEON Ltd.
Via
GlobeNewswire
Tickers
VEON
Aligos Therapeutics Presents Positive Data at HEP-DART 2025
December 11, 2025
From
Aligos Therapeutics
Via
GlobeNewswire
Tickers
ALGS
Stryker declares an $0.88 per share quarterly dividend
December 11, 2025
From
Stryker Corporation
Via
GlobeNewswire
Tickers
SYK
Absci Reports New Human Ex Vivo Data Demonstrating That ABS-201™ Stimulates Hair Growth and Regenerates Stem Cell Niche to Potentially Reverse Follicle Miniaturization
December 11, 2025
From
Absci Corporation
Via
GlobeNewswire
Tickers
ABSI
Hope for PDCD Foundation Delivers Petition to FDA Urging Approval of the First Targeted PDCD Treatment
December 11, 2025
From
Hope for PDCD Foundation
Via
GlobeNewswire
Cemtrex Highlights Profitability Focus, Strategic Transformation, and Progress Toward Portfolio Expansion
December 11, 2025
From
Cemtrex Inc.
Via
GlobeNewswire
Tickers
CETX
CETXP
Innventure Set to Join the Russell 2000®, Russell 3000®, and Russell Microcap® Indexes
December 11, 2025
From
Innventure, Inc.
Via
GlobeNewswire
Tickers
INV
Elicio Therapeutics Reports Antigen Spreading to Patient-Specific Neoantigens Beyond mKRAS in Ongoing Phase 2 AMPLIFY-7P Trial
December 11, 2025
From
Elicio Therapeutics Inc.
Via
GlobeNewswire
Tickers
ELTX
Streamex Corp. (NASDAQ: STEX) Acquires 9.9% Strategic Equity Stake in Royalty and Streaming Firm Empress Royalty Corp. Through a Premium Priced Share-for-Share Transaction at US$5.00 STEX with a Leading Institutional Investment Firm
December 11, 2025
From
Streamex Corp.
Via
GlobeNewswire
Tickers
STEX
TSX-V:EMPR
Praxis Precision Medicines Announces Plans to File an NDA for Relutrigine in SCN2A and SCN8A Developmental and Epileptic Encephalopathies in Early 2026
December 11, 2025
From
Praxis Precision Medicines, Inc.
Via
GlobeNewswire
Tickers
PRAX
Veriff Identity Fraud Report: Online Fraud Continues to Rise, Hitting E-Commerce and Financial Services Hardest
December 11, 2025
From
Veriff
Via
GlobeNewswire
OTC Markets Group Welcomes Grayscale Bittensor Trust (TAO) to OTCQX
December 11, 2025
From
OTC Markets
Via
GlobeNewswire
Tickers
OTCM
Grayscale® Bittensor Trust (GTAO) Begins Trading on OTC Markets and is Now SEC Reporting
December 11, 2025
From
Grayscale Investments
Via
GlobeNewswire
Tickers
BCHG
DEFG
ETCG
FILG
GBAT
GLIV
EBANX drives the next phase of credit cards in LatAm with network tokenization for cross-border transactions
December 11, 2025
From
EBANX LTDA
Via
GlobeNewswire
byNordic Acquisition Corporation Announces Extension of Deadline to Complete Business Combination
December 11, 2025
From
byNordic Acquisition Corp
Via
GlobeNewswire
Tickers
BYNO
BYNOU
BYNOW
Autobahn Labs Forms Strategic Partnership with Astellas to Accelerate Academic Discoveries into New Medicines
December 11, 2025
From
Autobahn Labs
Via
GlobeNewswire
BitMEX Debuts New Mobile Trading Experience With Intuitive Design and Controls
December 11, 2025
From
BitMEX
Via
GlobeNewswire
Roivant Highlights Continued Pipeline Progress and Outlook for Company’s Next Phase of Growth at 2025 Investor Day
December 11, 2025
From
Roivant Sciences
Via
GlobeNewswire
Tickers
ROIV
Patria Investments Announces Acquisition of RBR Gestão, adding US$ 1.5 bn in Listed Real Estate Investment Trusts (“REITs”) in Brazil
December 11, 2025
From
Patria Finance Limited
Via
GlobeNewswire
Tickers
PAX
Abeona Therapeutics® Announces New Qualified Treatment Center for ZEVASKYN® in Texas
December 11, 2025
From
Abeona Therapeutics Inc.
Via
GlobeNewswire
Tickers
ABEO
Rhythm Pharmaceuticals Announces Preliminary Data from Exploratory Phase 2 Trial that showed Setmelanotide Demonstrated Positive Efficacy Signal in Prader-Willi Syndrome
December 11, 2025
From
Rhythm Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
RYTM
Bastion Strengthens US Public Relations Offering with New Hire Jody Sowa as Managing Director
December 11, 2025
From
Bastion Agency
Via
GlobeNewswire
AC Immune Positive Interim Phase 2 Data on ACI-7104.056 Support Potential Slowing of Progression of Parkinson’s Disease
December 11, 2025
From
AC Immune SA
Via
GlobeNewswire
Tickers
ACIU
Immatics Presents IMA203CD8 PRAME Cell Therapy Data from Ongoing Dose Escalation and Shows Promising Initial Anti-tumor Activity in PRAME-Positive Tumors at ESMO-IO 2025 Congress
December 11, 2025
From
https://immatics.com/
Via
GlobeNewswire
Tickers
IMTX
Purple Biotech Reports Positive New Preclinical Data Demonstrating Multi-Arm Anti-Tumor Activity Across Two CAPTN-3 Tri-Specific Antibodies at ESMO Immuno-Oncology Congress 2025
December 11, 2025
From
Purple Biotech Ltd.
Via
GlobeNewswire
Tickers
PPBT
AtaiBeckley Announces New U.S. Patent Granted for EMP-01, Strengthening Intellectual Property Portfolio
December 11, 2025
From
AtaiBeckley N.V.
Via
GlobeNewswire
Tickers
ATAI
Iridex Announces the Publication of an Independent Study Demonstrating Safe and Effective Retreatment with Transscleral Laser Treatment Using MicroPulse® Technology in Glaucoma Management
December 11, 2025
From
IRIDEX Corporation
Via
GlobeNewswire
Tickers
IRIX
Prolynx Secures $70 Million Series A to Advance Portfolio of Ultra-Long-Acting Obesity Candidates and Appoints Chris Boulton as Chief Executive Officer
December 11, 2025
From
ProLynx Inc.
Via
GlobeNewswire
< Previous
1
2
...
10
11
12
13
14
15
16
17
18
...
99
100
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.